Literature DB >> 2041078

Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells.

R Shibata1, M Kawamura, H Sakai, M Hayami, A Ishimoto, A Adachi.   

Abstract

We constructed five chimeric clones between human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIVMAC) and four SIVMAC mutants by recombinant DNA techniques. Three chimeric clones and all mutants with an alteration in either the vif, vpx, vpr, or nef gene were infectious to human CD4-positive cell lines. The susceptibility of macaque monkey peripheral blood mononuclear cells (PBMC) to infection by these mutants and chimeras was examined in vitro. Macaque PBMC supported the replication of wild-type and vpx, vpr, and nef mutant SIVMAC strains. A chimera carrying the long terminal repeats (LTRs), gag, pol, vif, and vpx of SIVMAC and tat, rev, vpu, and env of HIV-1 was also replication competent in PBMC. In contrast, HIV-1, the vif mutant of SIVMAC, a chimera containing rev and env of SIVMAC, and a chimera containing vpx, vpr, tat, rev, and env of SIVMAC did not grow in PBMC. Western immunoblotting analysis of the replicating chimera in PBMC confirmed the hybrid nature of the virus. These data strongly suggested that the sequence important for macaque cell tropism lies within the LTR, gag, pol, and/or vif sequences of the SIVMAC genome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041078      PMCID: PMC241342     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Generation and characterization of infectious chimeric clones between human immunodeficiency virus type 1 and simian immunodeficiency virus from an African green monkey.

Authors:  R Shibata; H Sakai; T Kiyomasu; A Ishimoto; M Hayami; A Adachi
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

2.  HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain.

Authors:  W A O'Brien; Y Koyanagi; A Namazie; J Q Zhao; A Diagne; K Idler; J A Zack; I S Chen
Journal:  Nature       Date:  1990-11-01       Impact factor: 49.962

3.  Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.

Authors:  H Kestler; T Kodama; D Ringler; M Marthas; N Pedersen; A Lackner; D Regier; P Sehgal; M Daniel; N King
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

4.  Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects.

Authors:  G Franchini; P Markham; E Gard; K Fargnoli; S Keubaruwa; L Jagodzinski; M Robert-Guroff; P Lusso; G Ford; F Wong-Staal
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation.

Authors:  C Cheng-Mayer; M Quiroga; J W Tung; D Dina; J A Levy
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

6.  Complementation of the rev gene mutation among human and simian lentiviruses.

Authors:  H Sakai; R Shibata; T Miura; M Hayami; K Ogawa; T Kiyomasu; A Ishimoto; A Adachi
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

7.  Functional comparison of transactivation by human retrovirus rev and rex genes.

Authors:  H Sakai; H Siomi; H Shida; R Shibata; T Kiyomasu; A Adachi
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

9.  Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14.

Authors:  S Dewhurst; J E Embretson; D C Anderson; J I Mullins; P N Fultz
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

10.  Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome.

Authors:  D York-Higgins; C Cheng-Mayer; D Bauer; J A Levy; D Dina
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

View more
  85 in total

1.  An intracellular block to primate lentivirus replication.

Authors:  Jonathan P Stoye
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

2.  A20 targets caspase-8 and FADD to protect HTLV-I-infected cells.

Authors:  Y Saitoh; A Hamano; K Mochida; A Kakeya; M Uno; E Tsuruyama; H Ichikawa; F Tokunaga; A Utsunomiya; T Watanabe; S Yamaoka
Journal:  Leukemia       Date:  2015-10-06       Impact factor: 11.528

3.  Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.

Authors:  R Shibata; C Siemon; S C Czajak; R C Desrosiers; M A Martin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 4.  Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection.

Authors:  Jeremy Luban
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 and related primate lentiviruses engage clathrin through Gag-Pol or Gag.

Authors:  Sergei Popov; Bettina Strack; Victor Sanchez-Merino; Elena Popova; Heike Rosin; Heinrich G Göttlinger
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

6.  Functional analysis of vif genes derived from various primate immunodeficiency viruses.

Authors:  Y Yamamoto; Y Saito; S Iida; J Asano; S Sone; A Adachi
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

7.  Complete inhibition of SIVmac replication by its capsid mutants.

Authors:  R Shimano; R Inubushi; K Amano; T Ogasawara; H Akari; A H Koyama; M Kawamura; A Adachi
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

8.  Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors.

Authors:  K Uberla; C Stahl-Hennig; D Böttiger; K Mätz-Rensing; F J Kaup; J Li; W A Haseltine; B Fleckenstein; G Hunsmann; B Oberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

9.  Inhibition of human immunodeficiency virus type 1 virion entry by dominant-negative Hck.

Authors:  K Tokunaga; E Kiyokawa; M Nakaya; N Otsuka; A Kojima; T Kurata; M Matsuda
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Simian immunodeficiency virus DNA vaccine trial in macaques.

Authors:  S Lu; J Arthos; D C Montefiori; Y Yasutomi; K Manson; F Mustafa; E Johnson; J C Santoro; J Wissink; J I Mullins; J R Haynes; N L Letvin; M Wyand; H L Robinson
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.